

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 8.00868237 |
| 2 | negative regulation of cell killing (GO:0031342) | 8.00868237 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.68323363 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.40227601 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 6.35807487 |
| 6 | response to interleukin-15 (GO:0070672) | 6.07757797 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.01640160 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.00814615 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 6.00785318 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.60984836 |
| 11 | leukocyte aggregation (GO:0070486) | 5.60792957 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.50631114 |
| 13 | activated T cell proliferation (GO:0050798) | 5.33774186 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.81894186 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.80752771 |
| 16 | negative T cell selection (GO:0043383) | 4.77954954 |
| 17 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.74881302 |
| 18 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.68625891 |
| 19 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.68625891 |
| 20 | T cell migration (GO:0072678) | 4.67636620 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.64988765 |
| 22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.58438267 |
| 23 | neutrophil activation (GO:0042119) | 4.44721506 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.35934813 |
| 25 | detection of bacterium (GO:0016045) | 4.25798016 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.25507432 |
| 27 | granulocyte activation (GO:0036230) | 4.20804911 |
| 28 | detection of other organism (GO:0098543) | 4.20697426 |
| 29 | positive T cell selection (GO:0043368) | 4.08644231 |
| 30 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.06607176 |
| 31 | cellular extravasation (GO:0045123) | 4.01764240 |
| 32 | thymic T cell selection (GO:0045061) | 3.93222660 |
| 33 | interferon-gamma production (GO:0032609) | 3.91748086 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 3.88630409 |
| 35 | regulation of B cell differentiation (GO:0045577) | 3.85795983 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.83541690 |
| 37 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.81096959 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.80655716 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.78295546 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.78295546 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.78295546 |
| 42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.78295546 |
| 43 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.78295546 |
| 44 | modulation by symbiont of host immune response (GO:0052553) | 3.78295546 |
| 45 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.76916714 |
| 46 | T cell selection (GO:0045058) | 3.76238446 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 3.73171954 |
| 48 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.68938679 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 3.68274101 |
| 50 | leukocyte degranulation (GO:0043299) | 3.68010540 |
| 51 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.66477611 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.64752250 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.63817158 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.61916942 |
| 55 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.61824565 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.61632407 |
| 57 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.60065711 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 3.56435922 |
| 59 | negative regulation of phagocytosis (GO:0050765) | 3.55822634 |
| 60 | immunoglobulin mediated immune response (GO:0016064) | 3.43428162 |
| 61 | regulation of tolerance induction (GO:0002643) | 3.40627764 |
| 62 | positive regulation of granulocyte differentiation (GO:0030854) | 3.39248253 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.36728639 |
| 64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.36491597 |
| 65 | cellular defense response (GO:0006968) | 3.35620223 |
| 66 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.34112881 |
| 67 | megakaryocyte development (GO:0035855) | 3.33849471 |
| 68 | regulation of regulatory T cell differentiation (GO:0045589) | 3.30823590 |
| 69 | regulation of mast cell activation (GO:0033003) | 3.28289180 |
| 70 | regulation of cell killing (GO:0031341) | 3.27195949 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23851623 |
| 72 | respiratory burst (GO:0045730) | 3.23627637 |
| 73 | positive regulation of cell killing (GO:0031343) | 3.22622167 |
| 74 | microglial cell activation (GO:0001774) | 3.16066088 |
| 75 | detection of external biotic stimulus (GO:0098581) | 3.12644732 |
| 76 | positive regulation of isotype switching (GO:0045830) | 3.12587184 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.11680050 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 3.11627088 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.11627088 |
| 80 | lymphocyte migration (GO:0072676) | 3.11443929 |
| 81 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.11028455 |
| 82 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.10221364 |
| 83 | negative regulation of innate immune response (GO:0045824) | 3.08350003 |
| 84 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08289294 |
| 85 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08289294 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 3.03959032 |
| 87 | cytidine deamination (GO:0009972) | 3.03122177 |
| 88 | cytidine metabolic process (GO:0046087) | 3.03122177 |
| 89 | cytidine catabolic process (GO:0006216) | 3.03122177 |
| 90 | T cell receptor signaling pathway (GO:0050852) | 3.01243854 |
| 91 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.98938115 |
| 92 | mast cell activation (GO:0045576) | 2.98220554 |
| 93 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.96315149 |
| 94 | regulation of platelet aggregation (GO:0090330) | 2.96077675 |
| 95 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.91777523 |
| 96 | type I interferon signaling pathway (GO:0060337) | 2.91473618 |
| 97 | cellular response to type I interferon (GO:0071357) | 2.91473618 |
| 98 | response to type I interferon (GO:0034340) | 2.90300143 |
| 99 | B cell mediated immunity (GO:0019724) | 2.88208389 |
| 100 | leukocyte cell-cell adhesion (GO:0007159) | 2.86103084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.73217568 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.58090274 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.55526679 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.95179867 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.91422724 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.60307105 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.32698384 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.12050918 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.90306125 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86438076 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.81715784 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.77969740 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77607716 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.71874811 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.65361055 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.61574893 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.58943008 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.55781067 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.55348340 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.53325116 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.51321720 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50861024 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49030529 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46593774 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.45601726 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32956353 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32902321 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 2.28308719 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 2.25412562 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.21885648 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18196054 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18089888 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17974699 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07534240 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.07139121 |
| 36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.04388144 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 2.03663208 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.99645467 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89380890 |
| 40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79750291 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79616178 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78827624 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.72801103 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66732768 |
| 45 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.66135078 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63468544 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62297810 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61084201 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56470152 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56290322 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55411147 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54528018 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52604304 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50860644 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.48728696 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46019155 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39246382 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37871694 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36865193 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36634040 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36257781 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31415957 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31056847 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28006271 |
| 65 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23258047 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23131947 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23020246 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22889142 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21884685 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21847466 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21080157 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20793503 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20700776 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19813091 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18114359 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17043597 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16293627 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15455329 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14436338 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10376147 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07974067 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06518928 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06455333 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04528080 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04062275 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01384987 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00787019 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00584705 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00306836 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00074818 |
| 91 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98218199 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96532257 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92076329 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92060504 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91884819 |
| 96 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.90400385 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89079144 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88961498 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86395781 |
| 100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83719093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.64206902 |
| 2 | MP0003724_increased_susceptibility_to | 4.59347538 |
| 3 | MP0003436_decreased_susceptibility_to | 4.20742811 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.98600093 |
| 5 | MP0006082_CNS_inflammation | 3.73054111 |
| 6 | MP0005464_abnormal_platelet_physiology | 3.69401781 |
| 7 | MP0003763_abnormal_thymus_physiology | 3.58611763 |
| 8 | MP0001800_abnormal_humoral_immune | 3.19503623 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.03141074 |
| 10 | MP0005025_abnormal_response_to | 2.83508283 |
| 11 | MP0002723_abnormal_immune_serum | 2.77996367 |
| 12 | MP0003303_peritoneal_inflammation | 2.74827597 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.74008010 |
| 14 | MP0005387_immune_system_phenotype | 2.71631320 |
| 15 | MP0001790_abnormal_immune_system | 2.71631320 |
| 16 | MP0001819_abnormal_immune_cell | 2.70976189 |
| 17 | MP0002419_abnormal_innate_immunity | 2.69024352 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.56956415 |
| 19 | MP0000685_abnormal_immune_system | 2.51469300 |
| 20 | MP0009785_altered_susceptibility_to | 2.49482014 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.40923577 |
| 22 | MP0002405_respiratory_system_inflammati | 2.37159621 |
| 23 | MP0002398_abnormal_bone_marrow | 2.36659117 |
| 24 | MP0002132_abnormal_respiratory_system | 2.31138783 |
| 25 | MP0000716_abnormal_immune_system | 2.10828279 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.10510626 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.07320779 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 2.03481138 |
| 29 | MP0003866_abnormal_defecation | 1.98267663 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.96678783 |
| 31 | MP0000703_abnormal_thymus_morphology | 1.96563266 |
| 32 | MP0002722_abnormal_immune_system | 1.88185803 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.87140094 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.74738104 |
| 35 | MP0002429_abnormal_blood_cell | 1.72656908 |
| 36 | MP0001851_eye_inflammation | 1.64865391 |
| 37 | MP0001873_stomach_inflammation | 1.64262463 |
| 38 | MP0004947_skin_inflammation | 1.57940559 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.57291049 |
| 40 | MP0003690_abnormal_glial_cell | 1.56542951 |
| 41 | MP0008260_abnormal_autophagy | 1.49634563 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.44903679 |
| 43 | MP0000858_altered_metastatic_potential | 1.44004808 |
| 44 | MP0004381_abnormal_hair_follicle | 1.42502683 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.42489607 |
| 46 | MP0004510_myositis | 1.35281039 |
| 47 | MP0003828_pulmonary_edema | 1.34035685 |
| 48 | MP0008469_abnormal_protein_level | 1.29326569 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.22518691 |
| 50 | MP0005310_abnormal_salivary_gland | 1.13536193 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.12547848 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.11039559 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.07803280 |
| 54 | MP0004883_abnormal_blood_vessel | 1.06611799 |
| 55 | MP0002933_joint_inflammation | 1.06592032 |
| 56 | MP0008004_abnormal_stomach_pH | 1.03357928 |
| 57 | MP0005451_abnormal_body_composition | 1.00915811 |
| 58 | MP0001663_abnormal_digestive_system | 0.99865842 |
| 59 | MP0002166_altered_tumor_susceptibility | 0.99716494 |
| 60 | MP0004130_abnormal_muscle_cell | 0.99556812 |
| 61 | MP0003448_altered_tumor_morphology | 0.99455464 |
| 62 | MP0000490_abnormal_crypts_of | 0.99174406 |
| 63 | MP0001545_abnormal_hematopoietic_system | 0.99162097 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 0.99162097 |
| 65 | MP0009764_decreased_sensitivity_to | 0.98757829 |
| 66 | MP0009763_increased_sensitivity_to | 0.98313840 |
| 67 | MP0000015_abnormal_ear_pigmentation | 0.94025072 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.86836238 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 0.86431026 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.84639026 |
| 71 | MP0000569_abnormal_digit_pigmentation | 0.83106983 |
| 72 | MP0000343_altered_response_to | 0.81172387 |
| 73 | MP0005166_decreased_susceptibility_to | 0.76730388 |
| 74 | MP0005390_skeleton_phenotype | 0.72599905 |
| 75 | MP0005164_abnormal_response_to | 0.72102913 |
| 76 | MP0009278_abnormal_bone_marrow | 0.71047000 |
| 77 | MP0003075_altered_response_to | 0.70991045 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.69130239 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 0.67822368 |
| 80 | MP0005083_abnormal_biliary_tract | 0.66772570 |
| 81 | MP0002019_abnormal_tumor_incidence | 0.65643729 |
| 82 | MP0000249_abnormal_blood_vessel | 0.62968336 |
| 83 | MP0008874_decreased_physiological_sensi | 0.60589377 |
| 84 | MP0003045_fibrosis | 0.59423920 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.59012634 |
| 86 | MP0003795_abnormal_bone_structure | 0.58982327 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.56684142 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.55845078 |
| 89 | MP0005381_digestive/alimentary_phenotyp | 0.54907106 |
| 90 | MP0005174_abnormal_tail_pigmentation | 0.54641924 |
| 91 | MP0001853_heart_inflammation | 0.54461674 |
| 92 | MP0002006_tumorigenesis | 0.50698650 |
| 93 | MP0008873_increased_physiological_sensi | 0.48356552 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.46673640 |
| 95 | MP0004142_abnormal_muscle_tone | 0.46560183 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.45689477 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.45266462 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.44402687 |
| 99 | MP0000920_abnormal_myelination | 0.42721419 |
| 100 | MP0006054_spinal_hemorrhage | 0.40937370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.91553032 |
| 2 | Abnormality of macrophages (HP:0004311) | 5.45443833 |
| 3 | Prolonged bleeding time (HP:0003010) | 5.40188138 |
| 4 | T lymphocytopenia (HP:0005403) | 5.33905906 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.33690888 |
| 6 | Myositis (HP:0100614) | 5.20457727 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.07475822 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.92079516 |
| 9 | Stomatitis (HP:0010280) | 4.82701009 |
| 10 | Orchitis (HP:0100796) | 4.56364621 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.44542373 |
| 12 | Optic neuritis (HP:0100653) | 4.44542373 |
| 13 | Encephalitis (HP:0002383) | 4.38657353 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.14531998 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.11762355 |
| 16 | Spontaneous hematomas (HP:0007420) | 4.11305864 |
| 17 | Epistaxis (HP:0000421) | 4.07721835 |
| 18 | Pustule (HP:0200039) | 4.06076238 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 4.06000405 |
| 20 | Meningitis (HP:0001287) | 4.04791139 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.00086574 |
| 22 | Obstructive lung disease (HP:0006536) | 3.98168444 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.98168444 |
| 24 | Petechiae (HP:0000967) | 3.95489498 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.87303439 |
| 26 | Abnormality of T cells (HP:0002843) | 3.75410047 |
| 27 | Gingival bleeding (HP:0000225) | 3.71109596 |
| 28 | Joint swelling (HP:0001386) | 3.70098023 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66747774 |
| 30 | Purpura (HP:0000979) | 3.60633364 |
| 31 | Increased IgM level (HP:0003496) | 3.50267732 |
| 32 | Abnormal platelet volume (HP:0011876) | 3.46125102 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 3.34745713 |
| 34 | Menorrhagia (HP:0000132) | 3.30223434 |
| 35 | Chest pain (HP:0100749) | 3.27282605 |
| 36 | Recurrent skin infections (HP:0001581) | 3.25357825 |
| 37 | Keratoconjunctivitis sicca (HP:0001097) | 3.17832151 |
| 38 | Granulocytopenia (HP:0001913) | 3.14563840 |
| 39 | Recurrent viral infections (HP:0004429) | 3.14218423 |
| 40 | Vasculitis (HP:0002633) | 3.09690920 |
| 41 | Leukocytosis (HP:0001974) | 3.05502006 |
| 42 | Increased IgE level (HP:0003212) | 2.95050887 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.92574797 |
| 44 | Gingivitis (HP:0000230) | 2.92237151 |
| 45 | Eosinophilia (HP:0001880) | 2.91414369 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87390881 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87390881 |
| 48 | Severe combined immunodeficiency (HP:0004430) | 2.86241384 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.81314559 |
| 50 | Increased mean platelet volume (HP:0011877) | 2.81087081 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.80062337 |
| 52 | Arterial thrombosis (HP:0004420) | 2.73157581 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.70044714 |
| 54 | Lymphopenia (HP:0001888) | 2.66817377 |
| 55 | Episodic fever (HP:0001954) | 2.66130945 |
| 56 | Anorexia (HP:0002039) | 2.65308331 |
| 57 | Pulmonary embolism (HP:0002204) | 2.62551704 |
| 58 | Urticaria (HP:0001025) | 2.60031996 |
| 59 | Increased serum ferritin (HP:0003281) | 2.56605394 |
| 60 | Hemiplegia (HP:0002301) | 2.55091205 |
| 61 | Nasal polyposis (HP:0100582) | 2.51159189 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.50561806 |
| 63 | IgM deficiency (HP:0002850) | 2.50420959 |
| 64 | Hemoptysis (HP:0002105) | 2.50345691 |
| 65 | Abnormality of the common coagulation pathway (HP:0010990) | 2.50271363 |
| 66 | Hypoproteinemia (HP:0003075) | 2.49243642 |
| 67 | Impaired platelet aggregation (HP:0003540) | 2.49003118 |
| 68 | Abnormal platelet function (HP:0011869) | 2.49003118 |
| 69 | Acute hepatic failure (HP:0006554) | 2.48787496 |
| 70 | Abnormality of eosinophils (HP:0001879) | 2.47789508 |
| 71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.47744782 |
| 72 | Autoimmune hemolytic anemia (HP:0001890) | 2.36943046 |
| 73 | Combined immunodeficiency (HP:0005387) | 2.32408571 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.32266825 |
| 75 | Hepatosplenomegaly (HP:0001433) | 2.27012434 |
| 76 | Hyperlipoproteinemia (HP:0010980) | 2.25540005 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.24719428 |
| 78 | Cellulitis (HP:0100658) | 2.21644763 |
| 79 | Gangrene (HP:0100758) | 2.18464195 |
| 80 | Hypochromic anemia (HP:0001931) | 2.17229370 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.15656067 |
| 82 | Papilledema (HP:0001085) | 2.14942552 |
| 83 | Chronic diarrhea (HP:0002028) | 2.05447584 |
| 84 | Abnormality of the pleura (HP:0002103) | 2.04274132 |
| 85 | Colitis (HP:0002583) | 2.03277529 |
| 86 | Increased CSF protein (HP:0002922) | 2.02611059 |
| 87 | Agammaglobulinemia (HP:0004432) | 2.02471811 |
| 88 | IgG deficiency (HP:0004315) | 2.01493875 |
| 89 | Abnormality of the nasal mucosa (HP:0000433) | 2.00765468 |
| 90 | Sepsis (HP:0100806) | 2.00061372 |
| 91 | Glomerulopathy (HP:0100820) | 1.99730205 |
| 92 | Arthralgia (HP:0002829) | 1.98718229 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 1.97640187 |
| 94 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96276099 |
| 95 | Papilloma (HP:0012740) | 1.90540262 |
| 96 | Verrucae (HP:0200043) | 1.90540262 |
| 97 | Acne (HP:0001061) | 1.90404341 |
| 98 | Amaurosis fugax (HP:0100576) | 1.88427672 |
| 99 | Vertigo (HP:0002321) | 1.87698960 |
| 100 | Viral hepatitis (HP:0006562) | 1.87488472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.64901697 |
| 2 | TXK | 4.16764194 |
| 3 | RIPK4 | 4.10245507 |
| 4 | FES | 3.06975689 |
| 5 | ZAP70 | 2.97595130 |
| 6 | CSK | 2.89483406 |
| 7 | BLK | 2.66597257 |
| 8 | BTK | 2.54548863 |
| 9 | PRPF4B | 2.51208183 |
| 10 | TAOK3 | 2.36966492 |
| 11 | GRK6 | 2.27693249 |
| 12 | TNK2 | 2.27066983 |
| 13 | TYK2 | 2.21176045 |
| 14 | EPHB1 | 2.19505071 |
| 15 | SYK | 2.08571961 |
| 16 | MAP2K3 | 2.08504141 |
| 17 | JAK1 | 2.01898432 |
| 18 | ERN1 | 2.00288921 |
| 19 | ITK | 1.91247452 |
| 20 | JAK3 | 1.87312065 |
| 21 | IRAK4 | 1.87012413 |
| 22 | FGR | 1.75067085 |
| 23 | HCK | 1.71616650 |
| 24 | LCK | 1.67914142 |
| 25 | LYN | 1.50703370 |
| 26 | MAP3K13 | 1.50517104 |
| 27 | TEC | 1.50452119 |
| 28 | SIK3 | 1.47969093 |
| 29 | STK10 | 1.38398481 |
| 30 | CSF1R | 1.33975199 |
| 31 | TAOK1 | 1.33658163 |
| 32 | TESK2 | 1.30537032 |
| 33 | MAP3K3 | 1.25445135 |
| 34 | MARK3 | 1.24639488 |
| 35 | MAP3K11 | 1.21955395 |
| 36 | JAK2 | 1.10205599 |
| 37 | PDK1 | 1.09415299 |
| 38 | IKBKE | 1.06613255 |
| 39 | PTK2B | 1.02189907 |
| 40 | PRKCQ | 1.00925327 |
| 41 | MAP3K14 | 0.94994611 |
| 42 | BMPR2 | 0.94827182 |
| 43 | KIT | 0.92570311 |
| 44 | IKBKB | 0.90605514 |
| 45 | MAP3K1 | 0.90527311 |
| 46 | KSR2 | 0.90108379 |
| 47 | TBK1 | 0.87414406 |
| 48 | FYN | 0.82589536 |
| 49 | KDR | 0.81314084 |
| 50 | MARK2 | 0.79815745 |
| 51 | BMX | 0.78992612 |
| 52 | MAPK12 | 0.78415994 |
| 53 | TRIB3 | 0.76206806 |
| 54 | SIK2 | 0.74257814 |
| 55 | PTK6 | 0.73264149 |
| 56 | PIK3CG | 0.72616655 |
| 57 | TGFBR2 | 0.69539983 |
| 58 | PIM1 | 0.66170422 |
| 59 | YES1 | 0.62093020 |
| 60 | PRKCH | 0.61764333 |
| 61 | PDPK1 | 0.61708583 |
| 62 | CDK4 | 0.61376656 |
| 63 | LRRK2 | 0.57957968 |
| 64 | PRKD2 | 0.57154169 |
| 65 | RET | 0.56700142 |
| 66 | FGFR4 | 0.56412570 |
| 67 | HIPK2 | 0.56079984 |
| 68 | MAP3K7 | 0.52499195 |
| 69 | GRK7 | 0.52370332 |
| 70 | FGFR3 | 0.51105054 |
| 71 | MAP2K6 | 0.51090044 |
| 72 | MAP3K10 | 0.50927759 |
| 73 | CDC42BPA | 0.46125719 |
| 74 | STK38 | 0.45765110 |
| 75 | STK11 | 0.45568208 |
| 76 | IRAK1 | 0.45104880 |
| 77 | MAP3K5 | 0.45015007 |
| 78 | MST4 | 0.44902884 |
| 79 | GRK5 | 0.44778318 |
| 80 | CDK19 | 0.44295606 |
| 81 | TAOK2 | 0.44251731 |
| 82 | DYRK1B | 0.38841689 |
| 83 | CAMKK1 | 0.38382993 |
| 84 | MELK | 0.35873556 |
| 85 | INSR | 0.35104706 |
| 86 | PRKD1 | 0.34926263 |
| 87 | MATK | 0.34646328 |
| 88 | NLK | 0.33494141 |
| 89 | MAPK7 | 0.33320301 |
| 90 | RAF1 | 0.33316298 |
| 91 | MAP3K2 | 0.33275735 |
| 92 | SGK3 | 0.32639700 |
| 93 | CAMKK2 | 0.32460039 |
| 94 | MAPKAPK2 | 0.30312555 |
| 95 | EPHA3 | 0.30233590 |
| 96 | PAK1 | 0.29742936 |
| 97 | MAPK11 | 0.29574481 |
| 98 | SMG1 | 0.25806573 |
| 99 | ABL1 | 0.24669696 |
| 100 | MOS | 0.23723432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.00536026 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.79548357 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.07391404 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.87121340 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.84654259 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.77013961 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.38979620 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32655589 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27063044 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.17331916 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.16935515 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14609476 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.05049370 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.93253115 |
| 15 | Platelet activation_Homo sapiens_hsa04611 | 1.90980484 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86262212 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85034547 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.77362732 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69454600 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.69257496 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61595320 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.56948724 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.55669532 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52173977 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34562806 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32657062 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31532548 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29629266 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22664330 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16933956 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16499283 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12815807 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11134722 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10691629 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.09553138 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.07309426 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.06841808 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06123416 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.05443785 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03146484 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.02236078 |
| 42 | Endocytosis_Homo sapiens_hsa04144 | 1.01677444 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01604252 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01187044 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99402526 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98662362 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91466495 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.91123368 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90110185 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89989789 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.88810503 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81547399 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76232452 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76129626 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.75280641 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74806905 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73786615 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72612440 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72306914 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71553015 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69562228 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.68818555 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68598143 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67546355 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67390299 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67058194 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.66470049 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65613716 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64255199 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64200712 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58976746 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58312508 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56849905 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55533758 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53594525 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52774821 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52772796 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52060221 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.50602186 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49336808 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45634242 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44789834 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44626163 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44239300 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42750879 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41492038 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41464568 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41218372 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41128331 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40344481 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39209475 |
| 92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34851892 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.33878440 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32107625 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31758374 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.30415138 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29916462 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28035407 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.27633302 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26366242 |

